This idea is supported by studies in adult SLE patients that reported lower disease activity in anti-DFS70 positive SLE patients (19, 21) and by a study in patients with dermatomyositis complicated by interstitial lung disease (including one patient with juvenile DM) where anti-DFS70 antibody levels increased upon disease remission (18). Here, PSIP1 is linked to juvenile dermatomyositis.